We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Half of Adults Classified with High Blood Pressure

By HospiMedica International staff writers
Posted on 05 Dec 2017
A new guideline by the American Heart Association (AHA; Dallas, TX, USA) defines high blood pressure as a reading of 130/80, meaning that 46% of adults in the United States are now identified as having high blood pressure.

Under the new guideline, the number of adults with hypertension will rise from 72 million under the previous standard to 103 million. More...
The number of men under age 45 with a diagnosis of hypertension will triple, and the prevalence among women under age 45 will double. The new diagnostic revision, the first since 2003, resulted from growing evidence that blood pressure lower than that previously considered normal greatly reduces the chances of heart attack and stroke, as well as overall risk of death.

According to the new guideline, anyone with at least a 10% risk of a heart attack or stroke in the next decade should aim for blood pressure below 130/80. This includes people with conditions such as heart disease, kidney disease, or diabetes, and just being over 65 years of age. But of the additional 14% of adults due to be classified with high blood pressure, only one in five will need medication, compared with the previous AHA 2003 guideline recommendation. Instead, the guideline emphasizes that doctors need to focus on a whole framework of healthier lifestyle changes for patients.

The recommendations for a heart-healthy diet include reducing salt and incorporating potassium-rich foods such as bananas, potatoes, avocados and dark leafy vegetables. The guideline also gives specific suggestions for weight loss, quitting cigarettes, cutting back on alcohol, and increasing physical activity. In addition, the AHA recommends that the atherosclerotic cardiovascular disease (ASCVD) algorithm, which is available online (www.cvriskcalculator.com), be used to calculate 10-year risk of heart disease or stroke, as the assessment may prompt more thorough doctor-patient interaction. The new guideline was published on November 13, 2017, in Hypertension.

“Yes, we will label more people hypertensive and give more medication, but we will save lives and money by preventing more strokes, cardiovascular events, and kidney failure,” said Professor Kenneth Jamerson, MD, PhD, of the University of Michigan Health System, one of 21 experts on the guideline writing committee. “Physicians ought to be calculating risk as they think about how to treat. If you are going to put money into the healthcare system, it’s to everyone’s advantage if we treat and prevent on this side of it, in early treatment.”

Contrary to the AHA guideline, the 2014 Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-8) evidence-based guideline increased the systolic treatment goal from less than 140/90 mm Hg to less than 150/90 mm Hg, although committee members did not recommend it unanimously. JNC-8 also changed targets for adults with chronic kidney disease (CKD) and diabetes from less than 130/80 mm Hg to the less than the 140/90 mm Hg target goal recommended for the general population.

Related Links:
American Heart Association



Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: The thin foetoscope is guided through the abdominal wall to the placenta. Small magnets in its tip react to an externally generated magnetic field, enabling the instrument to be bent with precision. The robotic platform is designed to occlude shared blood vessels in the placenta of twins with twin-to-twin transfusion syndrome. (Image Credit: created with BioRender.com, ETH Zurich)

Robotic Platform Advances Fetoscopic Treatment of Twin-to-Twin Transfusion Syndrome

Twin-to-twin transfusion syndrome is a life-threatening complication in monochorionic twin pregnancies caused by unbalanced placental blood flow. Definitive treatment requires endoscopic laser coagulation... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.